mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.004 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.005 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.006 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.007 |